-
A validation of the use of names to screen for risk of chronic hepatitis B in Victoria, Australia, 2001 to 2010
-
View Affiliations Hide AffiliationsJ MacLachlanjennifer.maclachlan mh.org.au
-
View Citation Hide Citation
Citation style for this article: . A validation of the use of names to screen for risk of chronic hepatitis B in Victoria, Australia, 2001 to 2010. Euro Surveill. 2013;18(47):pii=20638. https://doi.org/10.2807/1560-7917.ES2013.18.47.20638 Received: 11 Dec 2012
Abstract
The burden of chronic hepatitis B (CHB) is increasing in Australia, particularly in those born in the Asia-Pacific region, and nearly half are undiagnosed. Primary care clinicians have a key role in diagnosing CHB, however identification of patients at risk is hindered by lack of awareness and limited information on country of birth in patient records. This study evaluates the potential of a validated list of names associated with Asian country of birth as a screening tool to predict risk of CHB, by comparing it with surveillance records for all people diagnosed with CHB or salmonellosis in Victoria from 2001 to 2010, and analysed using standard screening tools. Name list match was associated with CHB notification, with over 60% of cases having one name matching the list (sensitivity), and nearly one third matching both given name and surname; less than 15% and 2% of salmonellosis notifications matched for one name and both names, respectively (false positives). These results show that more than half of notified cases of CHB would have been identified by this name list, and that it could be used in support of initiatives to improve diagnosis of patients with diseases associated with country of birth when limited information is available.
Full text loading...